The Link between ANRIL Gene RS4977574 Polymorphism and Common Atherosclerosis Cardiovascular Complications: A
Polina V Kniazkova1, Viktoriia Yu Harbuzova1, Vladyslav V Pokhmura1
1Department of Physiology and Pathophysiology with Medical Biology Course, Medical Institute of the Sumy State University, Sumy 40034, Ukraine.
Insights
The ANRIL rs4977574-GG genotype is linked to increased atherosclerosis and cardiovascular risks. This genetic marker may predict complications, particularly in the Ukrainian population.
Area of Science:
- Genetics
- Cardiovascular Medicine
- Molecular Biology
Background:
- Atherosclerosis and cardiovascular complications pose significant health challenges.
- Genetic factors play a crucial role in the development of these conditions.
- The ANRIL gene is implicated in cardiovascular disease risk.
Purpose of the Study:
- To investigate the association between the ANRIL rs4977574 polymorphism and the risk of atherosclerosis and cardiovascular complications.
- To explore the relationship between this polymorphism and lipid profiles.
- To determine the potential of rs4977574 as a genetic marker in a Ukrainian population.
Main Methods:
- Case-control study involving patients with acute coronary syndrome (ACS), patients with large artery stenosis (LAS), and healthy controls.
- Real-time PCR for ANRIL rs4977574 genotyping.
- Statistical analysis using SPSS software.
Main Results:
- A significant association was found between the rs4977574 polymorphism and the risk of atherosclerosis and cardiovascular complications under a recessive model (OR = 1.551, p = 0.025).
- The polymorphism was also linked to altered serum levels of total cholesterol (p = 0.021) and LDL (p = 0.022).
- Specifically, the rs4977574 polymorphism was associated with an increased risk of ACS (OR = 1.501, p = 0.048) but not LAS (p > 0.05).
Conclusions:
- The ANRIL rs4977574-GG genotype may serve as a genetic marker for atherosclerosis and cardiovascular complications.
- This finding holds potential significance for risk stratification and personalized medicine in the Ukrainian population.
- Further research is warranted to elucidate the precise mechanisms underlying this association.
Materials And Methods:
195 patients with ACS, 200 patients with LAS, and 234 control subjects were enrolled in this case-control study. Real-time PCR was used for ANRIL rs4977574 genotyping. SPSS software package (version 17.0, IBM, USA) was used for data analysis.
Results:
A significant association between rs4977574 polymorphism and the risk of atherosclerosis and cardiovascular complications was found under the recessive model regardless of adjustment for nongenetic risk factors (OR = 1.551; p = 0.025). Moreover, the link between rs4977574 locus and serum levels of total cholesterol (p = 0.021) and LDL (p = 0.022) was detected. A separate analysis in subgroups demonstrated the association of rs4977574 polymorphism with increased risk of ACS under the recessive model (OR = 1.501; p = 0.048). No relation between rs4977574 site and LAS development was revealed (p > 0.05).
Conclusion:
Obtained data suggested that ANRIL rs4977574-GG genotype can be a possible genetic marker for the development of atherosclerosis and cardiovascular complications in Ukrainian population.
Related Concept Videos
Coronary Artery Disease I: Introduction
Atherosclerosis I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Atherosclerosis III: Management
Single Nucleotide Polymorphisms-SNPs


